• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.

作者信息

Gantner P, Cuzin L, Allavena C, Cabie A, Pugliese P, Valantin M-A, Bani-Sadr F, Joly V, Ferry T, Poizot-Martin I, Garraffo R, Peytavin G, Fafi-Kremer S, Rey D

机构信息

Virology Laboratory, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

INSERM, UMR 1027, Toulouse, France.

出版信息

HIV Med. 2017 Oct;18(9):704-708. doi: 10.1111/hiv.12506. Epub 2017 Apr 26.

DOI:10.1111/hiv.12506
PMID:28444816
Abstract
摘要

相似文献

1
Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.多替拉韦和利匹韦林联合疗法作为简化治疗策略的疗效与安全性：一项队列研究
HIV Med. 2017 Oct;18(9):704-708. doi: 10.1111/hiv.12506. Epub 2017 Apr 26.
2
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.多替拉韦利匹韦林治疗成人 HIV-1 病毒学抑制维持治疗的疗效、安全性和耐受性：III 期、随机、非劣效性 SWORD-1 和 SWORD-2 研究。
Lancet. 2018 Mar 3;391(10123):839-849. doi: 10.1016/S0140-6736(17)33095-7. Epub 2018 Jan 6.
3
Dolutegravir-Rilpivirine, Dual Antiretroviral Therapy for the Treatment of HIV-1 Infection.多替拉韦利匹韦林，用于治疗人类免疫缺陷病毒 1 型感染的双重抗逆转录病毒治疗。
Ann Pharmacother. 2019 Aug;53(8):860-866. doi: 10.1177/1060028019831674. Epub 2019 Feb 13.
4
Pharmacokinetic drug evaluation of dolutegravir plus rilpivirine for the treatment of HIV.多替拉韦加rilpivirine治疗HIV的药代动力学药物评价
Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1183-1192. doi: 10.1080/17425255.2017.1361929. Epub 2017 Aug 30.
5
Two-drug regimens for treatment of naïve HIV-1 infection and as maintenance therapy.用于初治HIV-1感染治疗及维持治疗的双药方案。
Drug Des Devel Ther. 2018 Nov 1;12:3731-3740. doi: 10.2147/DDDT.S140767. eCollection 2018.
6
Dolutegravir plus rilpivirine dual therapy in treating HIV-1 infection.多替拉韦加rilpivirine双重疗法治疗HIV-1感染
Expert Opin Pharmacother. 2018 Jan;19(1):65-77. doi: 10.1080/14656566.2017.1417984. Epub 2017 Dec 22.
7
Dolutegravir-rilpivirine: first 2-drug regimen for HIV-positive adults.多替拉韦利匹韦林：首个适用于 HIV 阳性成人的二联治疗方案。
Expert Rev Anti Infect Ther. 2018 Dec;16(12):877-887. doi: 10.1080/14787210.2018.1544491. Epub 2018 Nov 14.
8
Dolutegravir Dual Therapy as Maintenance Treatment in HIV-Infected Patients: A Review.多替拉韦双药治疗作为人类免疫缺陷病毒（HIV）感染者的维持治疗：一项综述。
Ann Pharmacother. 2018 Jul;52(7):681-689. doi: 10.1177/1060028018758432. Epub 2018 Feb 14.
9
Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients.在有治疗经验的HIV患者中换用多替拉韦加rilpivirine双重疗法的有效性、安全性及成本
Ann Pharmacother. 2018 Jan;52(1):11-18. doi: 10.1177/1060028017728294. Epub 2017 Aug 24.
10
Dolutegravir and rilpivirine for the maintenance treatment of virologically suppressed HIV-1 infection.多替拉韦和利匹韦林用于治疗病毒学抑制的 HIV-1 感染的维持治疗。
Expert Rev Clin Pharmacol. 2018 Jun;11(6):561-570. doi: 10.1080/17512433.2018.1478726. Epub 2018 May 28.

引用本文的文献

1
Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review.HIV 感染者中紧急出现的多替拉韦耐药突变的流行情况：快速范围综述。
Viruses. 2024 Mar 4;16(3):399. doi: 10.3390/v16030399.
2
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV.两种含多替拉韦且分别联合利匹韦林或拉米夫定的方案治疗 HIV-1 病毒学抑制的 HIV 感染者的疗效和安全性。
Viruses. 2023 Apr 10;15(4):936. doi: 10.3390/v15040936.
3
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus.
抗逆转录病毒治疗后艾滋病毒感染者的 2 药方案与 3 药方案的临床结局。
Clin Infect Dis. 2021 Oct 5;73(7):e2323-e2333. doi: 10.1093/cid/ciaa1878.
4
Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV.非核苷类逆转录酶抑制剂与整合酶抑制剂联合抗击艾滋病毒。
Pharmaceuticals (Basel). 2020 Jun 11;13(6):122. doi: 10.3390/ph13060122.
5
Two's a Company, Three's a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naïve and Treatment-Experienced Patients Living with HIV-1.二人成伴，三人不欢：初治和经治的HIV-1感染者启动或换用双药抗逆转录病毒治疗方案的综述
Infect Dis Ther. 2020 Jun;9(2):185-208. doi: 10.1007/s40121-020-00290-w. Epub 2020 Mar 19.
6
Antiretroviral Treatment Simplification With 2-Drug Regimens: Impact of Transmitted Drug Resistance Mutations.采用双药方案简化抗逆转录病毒治疗：传播性耐药突变的影响
Open Forum Infect Dis. 2019 Dec 18;7(1):ofz535. doi: 10.1093/ofid/ofz535. eCollection 2020 Jan.
7
A systematic review of the genetic mechanisms of dolutegravir resistance.多替拉韦耐药的遗传机制的系统评价。
J Antimicrob Chemother. 2019 Nov 1;74(11):3135-3149. doi: 10.1093/jac/dkz256.
8
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients.在HIV-1感染患者中，从依曲韦林加雷特格韦向利匹韦林加度鲁特韦优化治疗后病毒抑制的维持情况。
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958218821657. doi: 10.1177/2325958218821657.
9
Dolutegravir/rilpivirine for the treatment of HIV-1 infection.多替拉韦/利匹韦林用于治疗HIV-1感染。
HIV AIDS (Auckl). 2018 Nov 2;10:215-224. doi: 10.2147/HIV.S157855. eCollection 2018.
10
Dolutegravir/Rilpivirine: A Review in HIV-1 Infection.多替拉韦/利匹韦林：用于治疗人类免疫缺陷病毒 1 型感染的药物评价。
Drugs. 2018 Nov;78(16):1741-1750. doi: 10.1007/s40265-018-1005-4.